Chiron Fluvirin Remediation Plan Includes Hiring Chief Microbiologist
Executive Summary
Chiron is hiring a chief microbiologist as part of the firm's remediation plan following the suspension of its license to manufacture Fluvirin at its Liverpool, England plant
You may also be interested in...
Novartis’ New Vaccine Division Takes On Evolving Market
Novartis' newly acquired vaccines unit will face an increasingly differentiated market for flu vaccines, Vaccine & Diagnostic Business CEO Jörg Reinhardt said
Novartis’ New Vaccine Division Takes On Evolving Market
Novartis' newly acquired vaccines unit will face an increasingly differentiated market for flu vaccines, Vaccine & Diagnostic Business CEO Jörg Reinhardt said
Chiron reduces flu vaccine production estimate
Chiron will produce 18 mil. to 26 mil. doses of its influenza vaccine Fluvirin for the 2005-06 flu season, the company said June 15. In April, the company estimated it would produce 25 mil.-30 mil. doses. The company expects FDA to inspect the facility in July to determine whether deficiencies noted in a warning letter issued in December have been resolved (1"The Pink Sheet" Dec. 20, 2004, p. 30)...